GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medidata Solutions Inc (NAS:MDSO) » Definitions » ROCE %

Medidata Solutions (Medidata Solutions) ROCE % : 1.39% (As of Jun. 2019)


View and export this data going back to 2009. Start your Free Trial

What is Medidata Solutions ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medidata Solutions's annualized ROCE % for the quarter that ended in Jun. 2019 was 1.39%.


Medidata Solutions ROCE % Historical Data

The historical data trend for Medidata Solutions's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medidata Solutions ROCE % Chart

Medidata Solutions Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.37 5.86 8.50 10.75 9.60

Medidata Solutions Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.88 9.17 6.59 3.01 1.39

Medidata Solutions ROCE % Calculation

Medidata Solutions's annualized ROCE % for the fiscal year that ended in Dec. 2018 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2018 )  (A: Dec. 2017 )(A: Dec. 2018 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2018 )  (A: Dec. 2017 )(A: Dec. 2018 )
=65.993/( ( (1061.233 - 429.056) + (913.212 - 170.702) )/ 2 )
=65.993/( (632.177+742.51)/ 2 )
=65.993/687.3435
=9.60 %

Medidata Solutions's ROCE % of for the quarter that ended in Jun. 2019 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2019 )  (Q: Mar. 2019 )(Q: Jun. 2019 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2019 )  (Q: Mar. 2019 )(Q: Jun. 2019 )
=11.54/( ( (996.702 - 172.622) + (1023.766 - 181.77) )/ 2 )
=11.54/( ( 824.08 + 841.996 )/ 2 )
=11.54/833.038
=1.39 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2019) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medidata Solutions  (NAS:MDSO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Medidata Solutions ROCE % Related Terms

Thank you for viewing the detailed overview of Medidata Solutions's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medidata Solutions (Medidata Solutions) Business Description

Traded in Other Exchanges
N/A
Address
350 Hudson Street, 9th Floor, New York, NY, USA, 10014
Medidata Solutions Inc provides cloud-based solutions for the clinical development programs of life sciences companies. Its customers include biopharmaceutical companies, device makers, contract research organizations, and academic institutions. The majority of the company's business comes from subscriptions to the Medidata Clinical Cloud, with the remainder of revenue coming from services. The Medidata Clinical Cloud provides solutions for study design and planning, data capture, patient activity measurement, risk-based monitoring, and payments. The services segment includes technology and support services and professional consulting services. The majority of the firm's revenue is generated within the United States.
Executives
Carlos Dominguez director C/O MEDIDATA SOLUTIONS, INC., 79 FIFTH AVENUE, 8TH FLOOR, NEW YORK NY 10003
Lee Shapiro director C/O ALLSCRIPTS HEALTCHARE SOLUTIONS, 2401 COMMERCE DR, LIBERTYVILLE IL 60048
Michael L Capone officer: Chief Operating Officer C/O DYNATRACE HOLDINGS LLC, 1601 TRAPELO ROAD, SUITE 116, WALTHAM MA 02451
Eileen Schloss officer: OUTGOING EVP, HUMAN RESOURCES C/O MEDIDATA SOLUTIONS, INC., 79 FIFTH AVENUE, 8TH FLOOR, NEW YORK NY 10003
Alan Mateo officer: EVP, Field Operations C/O VEEVA SYSTEMS, 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Insight Holdings Group, Llc 10 percent owner 1114 AVENUE OF THE AMERICAS, 36TH FLOOR, NEW YORK NY 10036

Medidata Solutions (Medidata Solutions) Headlines

From GuruFocus

Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,667 Shares

By GuruFocus Research GuruFocus Editor 03-08-2011

These Stocks Are More Than You Think

By Adam Lawrence Adam Lawrence 11-21-2016

Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 3,000 Shares

By GuruFocus Research GuruFocus Editor 02-03-2011

Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 13,667 Shares

By GuruFocus Research GuruFocus Editor 02-08-2011